Under the agreement, Sunstar plans to launch a variety of products using Wellmune WGP®and other Biothera immune-boosting ingredients in functional foods and beverages, oral care and skin care products. Biothera and Sunstar will collaborate to undertake clinical research in each of these applications.

“Biothera is pleased for the opportunity to become a platform technology for Sunstar, a world leader in oral, health and beauty care,” said Richard G. Mueller, Biothera chief executive officer. “It is gratifying to be associated with a company like Sunstar that has the science and technical expertise and market leadership to expand the applications of Wellmune in the very important oral and beauty care markets.”

“Sunstar is pleased to establish this strategic alliance with Biothera, a leader in immune health ingredients with significant scientific research.  This will allow us to bring innovative products and solutions to our consumers,” said Masakazu Nakamura, member of the board, Sunstar.